For research use only. Not for therapeutic Use.
EVT-401（Cat No.:I043859）is a small molecule inhibitor targeting the Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2), a key player in angiogenesis—the formation of new blood vessels. By inhibiting VEGFR-2 signaling, EVT-401 effectively blocks tumor growth and metastasis by preventing the development of blood vessels that supply nutrients to tumors. It is being studied for its potential in cancer therapy, particularly in solid tumors where angiogenesis is a critical driver of disease progression. Ongoing research aims to evaluate EVT-401’s safety, efficacy, and potential as a therapeutic agent in oncology.
| Synonyms | 2-[3-fluoro-4-(trifluoromethyl)phenyl]-N-[2-(1-hydroxypropan-2-yl)-6-methyl-1-oxoisoquinolin-5-yl]acetamide |
| Molecular Formula | C22H20F4N2O3 |
| Purity | ≥95% |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
